Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Asana Recovery Now Enrolled and Approved as a California COVID-19 Vaccination Program Site

Asana Recovery has successfully enrolled as a California COVID-19 Vaccination Program site and will administer Covid-19 vaccines to staff and patients who meet the criteria and guidelines.


News provided by

Asana Recovery

Apr 02, 2021, 05:00 ET

Share this article

Share toX

Share this article

Share toX

Asana Recovery provides, Inpatient (IOP), Outpatient, Detox Services for addiction treatment
Asana Recovery provides, Inpatient (IOP), Outpatient, Detox Services for addiction treatment

COSTA MESA, Calif., April 2, 2021 /PRNewswire-PRWeb/ -- Asana Recovery has successfully enrolled and was approved to be a California COVID-19 vaccination site. It will be able to administer, manage and report COVID-19 vaccinations given to its staff and patients who meet the criteria and guidelines set by the Centers of Disease Control (CDC) and by the California Department of Public Health (CDPH) for the state.

As a California COVID-19 Vaccination Program approved site, Asana Recovery has successfully met the program's requirements which includes, the ability to store the vaccine, staff training, as well as reporting the administration of the vaccine. The latter requires enrollment and approval to access the state's computerized immunization information system for California residents, which Asana Recovery has also successfully completed.

“With the pandemic’s continued spread, and with new strands emerging, we feel it is our duty and responsibility to help protect our clients and the general populations, as a percentage of our clients are transient. We feel that it is imperative that reside -Adam Shandrow, COO

Post this

Asana Recovery's licensed medical staff (LVN, RN) will administer the vaccine to its patients who meet the guidelines and criteria during the phased distribution of the COVID-19 vaccine. The organization will follow the established guidelines and make the changes or adjust as instructed by the CDC and CDPH.

Recent studies have shown evidence that suggest a link between Substance Use Disorders (SUD) and COVID-19 susceptibility. According to a study published in Molecular Psychiatry in September, 2020, analysis of hospital data records have shown that people with SUDs are at higher risk of contracting and suffering worse consequences from COVID-19. The study was based on data from more than 73 million patients at 360 U.S. hospitals. Of those patients over 10 percent (7.5 million) had an SUD and 12,030 had COVID-19.

The data pointed to the overrepresentation of people with SUDs among those with COVID-19, making up 15.6 percent of the COVID-19 group versus just 10.3 percent of the total sample. Risk of COVID-19 was highest in people diagnosed with SUD within the past year. Those diagnosed with opioid use disorder (OUD) were 10.2 times more likely than those without a recent SUD diagnosis to have COVID-19, followed by recent diagnosis of tobacco use disorder (8.2 times 00.more likely), alcohol use disorder (7.8 times), cocaine use disorder (6.5 times), and cannabis use disorder (5.3 times).

"With the pandemic's continued spread, and with new strands emerging, we feel it is our duty and responsibility to help protect our clients and the general populations, as a percentage of our clients are transient," says Adam Shandrow, COO of Asana Recovery. "We feel that it is imperative that residential treatment centers take responsibility to ensure that clients are vaccinated and help stop the spread of this horrible disease."

While vaccinations remain limited and administered in phases, Asana Recovery will respect and ensure the equitable distribution of the vaccine within the organization. As required, it will record and report administration of the vaccines to CAIR2 (California Immunization Registry).

Asana Recovery offers residential addiction treatment, providing a full-spectrum of services to its patients from detox, traditional, and alternative therapies. For more information about Asana Recovery treatment programs, visit http://www.AsanaRecovery.com

About Asana Recovery
Asana Recovery is a private, for-profit, health care organization located in Costa Mesa, California. Asana Recovery provides a complete and individualized addiction treatment program using traditional as well as innovative or alternative methods to treat addiction. It provides 24/7 supervised support with round-the-clock staff onsite. Its mission is to provide a healing environment where clients acknowledge and understand their addiction, embrace a lifestyle of productivity, and find the fulfillment that comes in serving others. Asana Recovery is accredited by The Joint Commission, ASAM Level of Care certified, CARF accredited, and licensed by the Department of Health Care Services (DHCS) in California. More information about Asana Recovery can be found online at http://www.asanarecovery.com.

###

Media Contact

Jemellee Ambrose, JP Ambrose Communications, +1 909-214-4642, [email protected]

SOURCE Asana Recovery

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.